• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Canada
  • United Kingdom
  • Subscribe
  • facebook
  • instagram
  • RSS
  • RSMUS.com

The Real Economy Blog

Search

  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences
Home > Coronavirus > CHART OF THE DAY: The race to find a coronavirus vaccine

CHART OF THE DAY: The race to find a coronavirus vaccine

Oct. 23, 2020 by Adam Lohr

  • email
  • Twitter
  • Facebook
  • Linkedin

Scientists have been working at a blistering pace to shorten the vaccine development cycle from years to months in order to take a coronavirus vaccine to market. With more than 190 such vaccines in development, there are several leading the pack.

Two trials, by AstraZeneca and Johnson & Johnson, had been halted because participants had become sick. But both were cleared to resume in recent days.

Here’s the latest on the development of vaccines, as of Oct. 15, according to The New York Times and the World Health Organization:

For more information on how the coronavirus is affecting midsize businesses, please visit the RSM Coronavirus Resource Center.

  • email
  • Twitter
  • Facebook
  • Linkedin

Related posts

  • Coronavirus concerns for rural health care

    The coronavirus has largely affected more populated areas in the United States, but if the outbreak spreads to rural areas, hospitals will be put to the test to handle the health crisis.

  • Amid resurgence of coronavirus, health care providers feel mounting pressure

    Despite the central role that health care providers have played in treating patients with the virus, the industry continues to face significant financial pressure. Without some kind of relief from the coming fiscal cliff, those providers could be…

  • Cybersecurity, amid coronavirus, remains a top risk in health care

    Cybersecurity remains a top risk within the health care industry as attackers are weaponizing COVID-19 and breaches continue to increase during the first quarter of 2020.

Filed Under: Coronavirus, Health Care Tagged With: coronavirus, Covid-19, vaccine

About Adam Lohr

Adam is an audit partner and life sciences senior analyst in RSM's cutting-edge industry eminence program. In addition to providing assurance services to his clients, he sits on RSM’s national life science team and leads the San Diego office life science practice.

His senior analyst responsibilities include advising the firm’s life sciences care clients and client servers as they work to navigate the rapidly changing industry environment. Adam regularly writes, presents and advises on capital markets, digital transformation, policy and other issues transforming life sciences. He is an instructor at the regional and national level, and is experienced in the application of ASC 606 revenue recognition for the technology and consumer products industries.

Adam has over 12 years of accounting and finance experience, serving private equity-backed and private closely held companies in the middle market. He specializes in providing financial audit services and helping clients respond to technical, regulatory and economic changes that impact their business.

Primary Sidebar

Other Regions

  • Canada
  • United Kingdom

Categories

  • Economics
  • Technology
  • Consumer Products
  • Industrials
  • Financial Services
  • Real Estate
  • Health Care
  • Life Sciences

Recent Health Care articles

5 things to know in life sciences: Week of Feb. 22

Feb. 26, 2021

Pandemic highlights the need for better use of data among health care providers

Feb. 24, 2021

CHART OF THE DAY: State disparity in mental health preparedness

Feb. 19, 2021

RSMUS.com links

The Real Economy

Middle Market Business Index

MMBI Special Reports

Footer

  • Facebook
  • Instagram
  • RSS

About The Real Economy Blog

The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy. It is offered as a complement to RSM’s macroeconomic thought leadership, including The Real Economy monthly publication and the proprietary RSM US Middle Market Business Index (MMBI).

© 2021 RSMUS.com | Privacy Policy | Cookie Policy

The Real Economy Blog
  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences